Advisory Services Network’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.1K | Buy |
+235
| New | +$12K | ﹤0.01% | 3467 |
|
|
2025
Q4 | – | Sell |
-50
| Closed | -$2.39K | – | 3968 |
|
|
2025
Q3 | $2.39K | Buy |
+50
| New | +$2.01K | ﹤0.01% | 3759 |
|
|
2024
Q1 | – | Sell |
-50
| Closed | -$1.45K | – | 3406 |
|
|
2023
Q4 | $1.45K | Buy |
+50
| New | +$1.33K | ﹤0.01% | 3468 |
|
|
2023
Q2 | – | Sell |
-55
| Closed | -$1.99K | – | 3411 |
|
|
2023
Q1 | $1.99K | Hold |
55
| – | – | ﹤0.01% | 3433 |
|
|
2022
Q4 | $1.96K | Buy |
+55
| New | +$1.91K | ﹤0.01% | 3439 |
|
|
2020
Q4 | – | Sell |
-224
| Closed | -$4.82K | – | 3682 |
|
|
2020
Q3 | $5K | Buy |
+224
| New | +$5.08K | ﹤0.01% | 2786 |
|
|
2020
Q1 | – | Sell |
-24
| Closed | -$1K | – | 3273 |
|
|
2019
Q4 | $1K | Sell |
24
-680
| -97% | -$16.5K | ﹤0.01% | 3007 |
|
|
2019
Q3 | $23K | Hold |
704
| – | – | ﹤0.01% | 1760 |
|
|
2019
Q2 | $23K | Buy |
704
+624
| +780% | +$21.4K | ﹤0.01% | 1758 |
|
|
2019
Q1 | $3K | Hold |
80
| – | – | ﹤0.01% | 2270 |
|
|
2018
Q4 | $3K | Hold |
80
| – | – | ﹤0.01% | 2230 |
|
|
2018
Q3 | $4K | Sell |
80
-42
| -34% | -$2.07K | ﹤0.01% | 2163 |
|
|
2018
Q2 | $7K | Sell |
122
-22
| -15% | -$1.14K | ﹤0.01% | 1925 |
|
|
2018
Q1 | $7K | Buy |
144
+25
| +21% | +$1.04K | ﹤0.01% | 2012 |
|
|
2017
Q4 | $5K | Hold |
119
| – | – | ﹤0.01% | 2124 |
|
|
2017
Q3 | $5K | Hold |
119
| – | – | ﹤0.01% | 1904 |
|
|
2017
Q2 | $5K | Buy |
119
+79
| +198% | +$2.81K | ﹤0.01% | 1831 |
|
|
2017
Q1 | $1K | Buy |
+40
| New | +$1.07K | ﹤0.01% | 2124 |
|
Other funds holding SUPN
VPM
VCM
NAMI
AC